Letter | 04 December 2021 COVID-19 The Lancet: Correspondence: Obligations in a global health emergency
Letter | 01 December 2021 COVID-19 CSO open letter to the Director General of the WTO on TRIPS Waiver
Letter | 15 October 2021 Tuberculosis Letter to Cepheid to reinstate launch of GeneXpert Omni TB testing system
Letter | 12 October 2021 COVID-19 South Africa: CSO letters to the embassies of countries opposing the TRIPS waiver
Letter | 08 October 2021 Tuberculosis IJTLD: Urine LAM diagnostics can close the deadly testing gap for TB
Letter | 09 August 2021 Hepatitis C Open letter to AbbVie to make glecaprevir/pibrentasvir (G/P) accessible for people with hepatitis C
Letter | 30 June 2021 COVID-19 United States of America Letters to US President and Trade Representative to swiftly implement IP waiver of all COVID-19 medical tools
Letter | 30 June 2021 COVID-19 European Union Letter to European Commission to stop blocking IP waiver of COVID-19 medical tools